Clinical Trial Update: Neulasta in Type 1 Diabetes [Phase 1]

View source ↗

Summary

Phase 1 trial of Neulasta (pegfilgrastim) in individuals with Type 1 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• NEULASTA (pegfilgrastim)

Snippet

Sponsor: University of Florida | Conditions: Type 1 Diabetes | Phase 1 | Status: COMPLETED